Skip to Content
MilliporeSigma
Search Within

215-168-2

Applied Filters:
Keyword:'215-168-2'
Showing 1-4 of 4 results for "215-168-2" within Papers
Fen Wang et al.
Brain research, 1147, 34-38 (2007-03-06)
Recent studies have demonstrated that cholesterol metabolism might play an important role in Alzheimer's disease (AD). Cholesterol 24-hydroxylase (CYP46) and ATP-binding cassette transporter A1 (ABCA1) have both been proposed to be involved in cholesterol metabolism in the brain. The purpose
Alessandro Biffi et al.
Archives of neurology, 67(6), 677-685 (2010-06-19)
To investigate whether genome-wide association study (GWAS)-validated and GWAS-promising candidate loci influence magnetic resonance imaging measures and clinical Alzheimer's disease (AD) status. Multicenter case-control study of genetic and neuroimaging data from the Alzheimer's Disease Neuroimaging Initiative. Multicenter GWAS. Patients A
Fen Wang et al.
Zhonghua yi xue za zhi, 87(9), 614-618 (2007-06-07)
To investigate the association of the single nucleotide polymorphisms (SNPs) A-->G in the intron 2 of cholesterol 24-hydroxylase (CYP46) gene and G-->A (R219K) in the exon 6 of ATP-binding cassette transporter A1 (ABCA1) gene with sporadic Alzheimer's disease (SAD) in
Sangyeoup Lee et al.
Metabolism: clinical and experimental, 58(2), 270-274 (2009-01-22)
Asian adults are at greater risk for metabolic abnormalities (insulin resistance, dyslipidemia) at the same body mass index (BMI) than are whites. Elevated free fatty acids (FFA) and decreased adiponectin are linked with these same metabolic abnormalities. We tested the
Page 1 of 1